Search by Drug Name or NDC

    NDC 53809-0202-04 DOMETUSS 4; 20; 10 mg/5mL; mg/5mL; mg/5mL Details

    DOMETUSS 4; 20; 10 mg/5mL; mg/5mL; mg/5mL

    DOMETUSS is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by Domel Laboratories. The primary component is CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 53809-0202
    Product ID 53809-202_6db8a77f-ba8d-419c-8999-6ca93ab9a919
    Associated GPIs
    GCN Sequence Number 000758
    GCN Sequence Number Description guaifenesin LIQUID 200 MG/5ML ORAL
    HIC3 B3J
    HIC3 Description EXPECTORANTS
    GCN 02510
    HICL Sequence Number 000271
    HICL Sequence Number Description GUAIFENESIN
    Brand/Generic Generic
    Proprietary Name DOMETUSS
    Proprietary Name Suffix n/a
    Non-Proprietary Name chlorpheniramine maleate, dextromethorphan hydrobromide, and phenylephrine hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 4; 20; 10
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name CHLORPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Domel Laboratories
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Rece
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 53809-0202-04 (53809020204)

    NDC Package Code 53809-202-04
    Billing NDC 53809020204
    Package 118 mL in 1 BOTTLE (53809-202-04)
    Marketing Start Date 2015-08-01
    NDC Exclude Flag N
    Pricing Information N/A